register

News & Trends - MedTech & Diagnostics

Health insurer unveils GUI funding plans post removal from Prescribed List

Health Industry Hub | March 11, 2024 |

MedTech & Diagnostics News: More than 500 General Use Items (GUIs) will no longer be included on the Prescribed List (PL) from 1 July 2024. The recent Senate Estimates honed in on the controversial decision by the government to abandon ship, shifting the GUI funding negotiations to private hospitals, health insurers, and medtech companies. The move has sparked questions about the scope of the negotiations and the future implications for patients.

“After the sector believed that there will be funding of General Use Items by a different mechanism, the Minister of Health said that was no longer the case,” said Senator Anne Ruston, Shadow Minister for Health and Aged Care, referring to the backtracking on announced plans by the Federal Minister of Health, Mark Butler.

GUIs include (but are not limited to) staples, staple applicators, clips and glues to close wounds. More than 70% of surgeries impacted by this funding change are performed on women, such as breast cancer operations, caesareans, and bariatric surgeries.

Bupa, the nation’s second-largest private health insurer, has announced its strategy regarding GUI funding post-July 1, with a transition to be completed by 2027.

The private health insurer stated “This ensures all Australian hospitals and our members continue receiving the same benefits and coverage for Listed GUIs on and from July 1 until Bupa has bundled the Listed GUIs with the benefit we currently pay for applicable procedures that use GUIs.

“This variation will be reflected in our agreement with contracted hospitals. From the date we vary our agreements with contracted hospitals, the hospital will cease claiming the applicable GUI benefits as the GUIs will be funded in the benefit we pay for the procedure claimed.”

For non-contracted hospitals, Bupa will also continue to fund Listed GUIs according to the existing schedule until the transition for bundling is finalised.

While Bupa acknowledged the evolving medtech sector and the innovative medical technology landscape, it is unlikely that the private insurer will pay higher benefits for new GUIs.

To illustrate their intention, Bupa provided two descriptive examples. The first involved a new generation GUI replacing an existing one by the same medtech company, and the second illustrated a new supplier offering a similar technology to an existing medtech company. Bupa emphasised that these claims would be processed at the same benefit rate or lower.

At the Estimates, Senator Ruston delved into the potential ramifications for patients, questioning, “Is the Department [of Health] satisfied that there won’t be any impact on patients as a result of this change in how General Use Items are being dealt with?”

The impact of this shift in GUI funding remains a topic of interest, with stakeholders closely monitoring negotiations as private health insurers take a more prominent role in shaping the funding criteria.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

New combination therapy improves survival rates for Aussies with advanced prostate cancer

New combination therapy improves survival rates for Aussies with advanced prostate cancer

Health Industry Hub | February 14, 2025 |

A world-first treatment approach has demonstrated significant advancements in the management of metastatic castration-resistant prostate cancer (mCRPC) compared to conventional […]

More


News & Trends - Pharmaceuticals

'Don't just learn what illness is, learn what it feels like,' Dr Ben Bravery

‘Don’t just learn what illness is, learn what it feels like,’ Dr Ben Bravery

Health Industry Hub | February 14, 2025 |

With the iconic Sydney Harbour as a backdrop, the Merck Healthcare team came together for a dynamic and engaging kick-off […]

More


News & Trends - MedTech & Diagnostics

GE HealthCare, Lumus Imaging and GenesisCare unite to bring advanced technology to patients

GE HealthCare, Lumus Imaging and GenesisCare unite to bring advanced technology to patients

Health Industry Hub | February 14, 2025 |

GE HealthCare and Lumus Imaging have joined forces to enhance medical care in Sydney’s Campbelltown region, unveiling a state-of-the-art imaging […]

More


News & Trends - MedTech & Diagnostics

World-First mobile CT for regional healthcare

World-First mobile CT for regional healthcare

Health Industry Hub | February 14, 2025 |

An Australian X-ray technology company developing a world-first full-body mobile CT following the award of an up to US$16.4m (A$25m) […]

More


This content is copyright protected. Please subscribe to gain access.